Favourable outcomes in folliculotropic mycosis fungoides after multimodality treatment in a single institution
J Eur Acad Dermatol Venereol
.
2021 Jan;35(1):e42-e45.
doi: 10.1111/jdv.16790.
Epub 2020 Jul 22.
Authors
C W Laggis
1
,
A Lamb
2
,
A M Secrest
1
3
,
N Ufkes
4
,
A S Halwani
2
5
,
R Tao
2
6
,
D Gaffney
2
6
,
R R Miles
2
7
8
,
S R Florell
1
,
D Wada
1
2
Affiliations
1
Department of Dermatology, University of Utah, Salt Lake City, UT, USA.
2
Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
3
Department of Population Health Sciences, University of Utah, Salt Lake City, UT, USA.
4
Medical University of South Carolina School of Medicine, Charleston, SC, USA.
5
Department of Oncology, University of Utah, Salt Lake City, UT, USA.
6
Department of Radiation Oncology, University of Utah, Salt Lake City, UT, USA.
7
Department of Pathology, University of Utah, Salt Lake City, UT, USA.
8
ARUP Laboratories, Salt Lake City, UT, USA.
PMID:
32594555
DOI:
10.1111/jdv.16790
No abstract available
Publication types
Letter
MeSH terms
Combined Modality Therapy
Humans
Mycosis Fungoides* / therapy
Skin Neoplasms* / therapy